Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)

Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab)

产品编号

YR1139

别名

科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Catumaxomab ( 卡妥索单抗 ), Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab
Catalog Number	YR1139
Molecular Name	Catumaxomab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2a Kappa/G2b Lambda
Formulation	PBS, pH7.5
Background	Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in people with metastasizing cancer. It binds to antigens CD3 and EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany).
CAS Number	509077-98-9
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	150.51 kDa
Target	CD3E & EpCAM[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0